Evoke Pharma, Inc.

5.12+0.22 (+4.49%)
Oct 29, 4:00:02 PM EDT · NasdaqCM · EVOK · USD

Upcoming Earnings

Report date
≈ -

Key Stats

Market Cap
7.98M
P/E (TTM)
-
Basic EPS (TTM)
-1.25
Dividend Yield
0%

Recent Filings

About

Evoke Pharma, Inc. operates as a specialty pharmaceutical company that focuses on the development and commercialization of drugs for the treatment of gastroenterological disorders and diseases. It offers Gimoti, a metoclopramide nasal spray to treat symptoms associated with acute and recurrent diabetic gastroparesis in adults. The company markets its products to gastroenterologists, internal medicine specialists, primary care physicians, and select health care providers. Evoke Pharma, Inc. was incorporated in 2007 and is based in Solana Beach, California.

CEO
Mr. Matthew J. D'Onofrio MBA
IPO
9/25/2013
Employees
3
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic